Roche to Pay $2.4 Billion for Full Control of Foundation Medicine

Roche said it would pay $2.4 billion to buy the shares it doesn’t already own in Foundation Medicine, furthering its bet on personalized cancer care.

from WSJ.com: US Business https://ift.tt/2K0qVe3
via IFTTT